Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …

Continue ›››

Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert

In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of …

Continue ›››

New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery

In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade …

Continue ›››

It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?

The year 2012 is often regarded as the beginning of the deep learning revolution.  That year, Alexnet, the deep learning …

Continue ›››

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

In the realm of clinical trials, efficient data management and monitoring are crucial yet often hampered by outdated and time-consuming …

Continue ›››

AI Integration Advances Lung Fibrosis Patient Stratification in Clinical Trials

In a collaborative effort between Brainomix, an AI-powered medical technology company, and AstraZeneca, a new study demonstrates significant advancements in …

Continue ›››

These 22 Biotechs Collectively Raised $3.3 Billion in Q1 2024. What Do They Have to Offer?

The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021.  …

Continue ›››

NVIDIA Introduces New Software Tools for Biopharma AI Applications

NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial …

Continue ›››

Denmark Collaborates with NVIDIA to Establish AI Innovation Centre Featuring Advanced Supercomputer

Denmark is set to create a national AI innovation centre in collaboration with NVIDIA, aiming to host one of the …

Continue ›››

AI Becomes a Drop-in Replacement for Docking

The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …

Continue ›››

Notable Trends and Companies to Follow in Neuroscience

Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …

Continue ›››

The Growing Momentum for AI Foundation Models in Biotech and 12 Notable Companies

As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic …

Continue ›››